HK$4.34
1.05%
Hong Kong, Oct 08, 03:51 pm HKT. Closed.
ISIN
HK0000311099
Symbol
3320

China Resources Pharmaceutic Stock price

HK$4.34
-0.15 3.34% 1M
-1.84 29.77% 6M
-0.11 2.47% YTD
-0.53 10.88% 1Y
-0.69 13.72% 3Y
+0.51 13.32% 5Y
-4.67 51.83% 10Y
-4.67 51.83% 20Y
Hong Kong, Closing price Thu, Oct 08 2026
+0.05 1.17%
Compare with Peer Group
ISIN
HK0000311099
Symbol
3320
Industry

Is China Resources Pharmaceutic a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,113 stocks worldwide.

Key metrics

Basic
Market capitalization
HK$27.1b
Enterprise Value
HK$72.2b
Net debt
HK$45.0b
Cash
HK$46.9b
Shares outstanding
6.3b
Valuation
P/E
5.6
P/S | estimate
0.1 | 0.1
EV/Sales | estimate
0.2 | 0.2
EV/FCF | ex SBC
- | -
P/B
0.4
Dividends
DPS
HK$0.24
Yield 1Y | 5Y
5.6% | 3.6%
Growth 1Y | 5Y
77.6% | 14.8%
Payout 1Y | 3Y
18.0% | 26.6%
Increased
1 Year
Financials
Revenue | estimate
HK$318.6b | HK$324.1b
EBITDA
-
EBIT
HK$15.7b
Net Income
HK$4.9b
Free Cash Flow | ex SBC
- | -
Growth
Revenue | estimate
4.3% | 2.7%
EBITDA
-
EBIT
5.3%
Net Income
47.2%
Free Cash Flow
-
Margin
Gross
16.4%
EBITDA
-
EBIT
4.9%
Net
1.5%
Free Cash Flow | ex SBC
- | -
Financial Health
Equity Ratio
18.0%
Return on Equity
7.9%
ROCE
9.1%
ROIC
6.8%
Debt/Equity
1.5
More
EPS
HK$0.8
FCF per Share
-
Short interest
-
Employees
86k
Rev per Employee
HK$3.7m

China Resources Pharmaceutic Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a China Resources Pharmaceutic forecast:

12x Buy
86%
2x Hold
14%

Analyst Opinions

14 Analysts have issued a China Resources Pharmaceutic forecast:

Buy
86%
Hold
14%

China Resources Pharmaceutic Events

Upcoming Event
OCT
22
Q4 2026 Earnings Call
in 14 days
View Past Earnings Reaction

Financial data from China Resources Pharmaceutic

Jun '26
+/-
%
318,582 318,582
4% 4%
100%
- Direct Costs 266,455 266,455
4% 4%
84%
52,127 52,127
8% 8%
16%
- Selling and Administrative Expenses 34,514 34,514
5% 5%
11%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 15,743 15,743
5% 5%
5%
Net Profit 4,863 4,863
47% 47%
2%

In millions HKD.

Don't miss a Thing! We will send you all news about China Resources Pharmaceutic directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

China Resources Pharmaceutical Group Ltd. is an investment holding, which engages in the research and development, manufacture, distribution, and retail of pharmaceutical and healthcare products. The company employs 85,600 full-time employees The company went IPO on 2016-10-28. The firm operates its business through four segments. The Pharmaceutical Business segment develops, manufactures and sells a range of pharmaceuticals and health products. The Pharmaceutical Distribution Business segment provides distribution, warehousing, logistics and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers, device manufacturer and dispensers, including hospitals, distributors and retail pharmacies. The Pharmaceutical Retail Business segment operates retail pharmacies. The Other Business Operations segment engages in property holding and other businesses.

Head office Hong Kong
Employees 85,600
Website www.crpharm.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today